CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Korean Drug Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Korean Drug Co Ltd
69-10, Wonjeok-Ro, Sindun-Myeon
Phone: +82 316347100p:+82 316347100 ICHEON, 17303  South Korea Ticker: 014570014570
Business Summary
Korean Drug Co Ltd is a Korea-based company primarily engaged in the manufacture of pharmaceuticals. The Company’s portfolio includes vitamins and nutritional supplements, central nervous system agents, dermatological agents, antibiotics and antimicrobials, digestive and respiratory system agents, comprehensive cold medicines, hematopoietic nutritional supplements, circulatory system agents, antipyretic, analgesic, and anti-inflammatory drugs, motion sickness medications, as well as other pharmaceuticals.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202512/31/2025Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2835 In vitro and in vivo diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Co-Chief Executive Officer Hae RyongPark 77 5/2/2005
President, Co-Chief Executive Officer, Director Sang HunPark 41 5/2/2005
Managing Director Gyeong DeukLee 64 3/20/2026 3/21/2008
5 additional Officers and Directors records available in full report.

Business Names
Business Name
014570
Korean Drug Co., Ltd.

General Information
Number of Employees: 238 (As of 12/31/2025)
Outstanding Shares: 10,819,663 (As of 12/31/2025)
Shareholders: 7,881
Stock Exchange: KDQ
Fax Number: +82 25296114


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, March 31, 2026